Results

Total Results: 537 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - See also: Print Summary for Patients. . . . . . . . . . . . . . . . . . . . . . . … Clinical trials that provide more information about the safety and effectiveness of other medications … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … professional judgment and patient preferences. … Offer/provide this service for selected patients depending on individual circumstances.
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
    May 24, 2022 - Editorial Multimedia Related article and JAMA Patient Page Supplemental content Related articles … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … 35 letters; P = .25 Bilateral visual impairment: 35% vs 47%; P = .17 Abbreviations: ACCS, Aged Care Client … Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two … Utility of a patient-response screening question for visual impairment.
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - Clinicians should inform patients of the potential benefits and harms of chemoprevention. … some high-risk women but will depend on breast cancer risk, risk for potential harms, and individual patient … efficacy for breast cancer chemoprevention are under way, including a trial comparing efficacy and safety … The USPSTF recommends that clinicians routinely provide [the service] to eligible patients. … The USPSTF recommends against routinely providing [the service] to asymptomatic patients.
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/yzXkWEQV3pn95yd_pmXZXk
    December 15, 2020 - Clinicians should understand the evidence but individualize decision-making to the specific patient or … Trials evaluated first-line therapies (ie, therapies with the highest proven efficacy and safety, including … Most studies ad- justed for patient age, sex, and stage of fibrosis; some also adjusted for level of … - penia or osteoporosis in patients treated with TDF or entecavir with patients receiving no therapy … Clinicians should understand the evidence but individualize decision-making to the specific patient or
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/vv5kXtX5QDg2948gog66pd
    December 07, 2021 - 2192. doi:10.1001/jama.2021.15658 Editorial page 2139 Multimedia Related article page 2172 and JAMA Patient … Data Extraction and Quality Assessment One investigator abstracted details about the study design, patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Oral health prevention and toddler well-child care: routine integration in a safety net system.
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/food-insecurity-screening
    March 11, 2025 - Clinicians should also be aware of the risk factors for food insecurity and listen to patient concerns … Clinicians should understand the evidence but individualize decision-making to the specific patient or … food insecurity, housing instability, transportation problems, utility help needs, and interpersonal safety … For example, a clinician may identify a patient with food insecurity, but if the patient or clinician … Development of indicators to assess hunger. J Nutr . 1990;120(Suppl 11):1544-1548.
  7. www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
    January 19, 2021 - with proven effectiveness and established safety. … safety I statement To whom does this recommendation apply? … Patient-centered medicine, a professional evolution. JAMA. 1996;275:152-156. … Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and … Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/yxCxm3XZ-zoAHc7dnN9aKB
    November 01, 2012 - See also: Print Summary for Patients. . . . . . . . . . . . . . . . . . . . . . . … or multiple-item patient ques- tionnaires (HHIE-S), and handheld audiometers. … It also clarified the patient population to which the recommenda- tion applies. … safety. … Clinicians may provide this service to selected patients depending on individual circumstances.
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-cancer-screening
    May 09, 2017 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Effectiveness of Early Detection and Treatment No studies directly compared patient health outcomes … it is uncertain whether earlier or immediate treatment vs delayed or no surgical treatment improves patientPatient age is significantly related to the progression of papillary microcarcinoma of the thyroid under … Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic
  10. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-3-topic-work-plan-development
    March 06, 2025 - This definition acknowledges the importance of the patient clinician relationship as facilitated and … be answered by the literature review in order for the Task Force to evaluate the effectiveness and safety … Similarly, analytic frameworks do not guide clinical decisionmaking for an individual patient, nor do … A clinical "sign" is not a health outcome that is not sensed by the patient; a clinical sign is analogous … These are not direct measures of health but are indicators of positive or negative effects on the larger
  11. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/depression-in-children-and-adolescents-screening
    February 08, 2016 - In summary, the Patient Health Questionnaire for Adolescents and BDI reported the highest sensitivity … The patients eligible for these trials may not be representative of all patients with MDD seen in primary … Screening and treating depression: patient preferences and implications for social workers. … serotonin reuptake inhibitors in pediatric depression: did unpublished studies influence the efficacy/safety … disorders among adolescent primary care patients.
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/efwy72cuMdhcF2jotkhTzC
    March 29, 2019 - professional judgment and patient preferences. … Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral … Comparative safety of antiretroviral treatment regimens in pregnancy. … Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening
    September 25, 2014 - The framework starts on the left with the patient population of interest, asymptomatic adults at increased … subspecialty clinics (e.g., oncology, rheumatology, dermatology, transplant) where TB screening in patients … employees for LTBI as part of a formal surveillance program for occupational exposure under Occupational Safety
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
    September 25, 2014 - The framework starts on the left with the patient population of interest, asymptomatic adults at increased … subspecialty clinics (e.g., oncology, rheumatology, dermatology, transplant) where TB screening in patients … employees for LTBI as part of a formal surveillance program for occupational exposure under Occupational Safety
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/blood-pressure-in-children-and-adolescents-hypertension-screening
    November 10, 2020 - The study enrolled healthy volunteers or patients referred for abnormal blood pressure who were 11 to … Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 … Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. … A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril … Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension.
  16. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
    January 26, 2016 - Data were sparse for Patient Health Questionnaire instruments. … but acknowledged there may be considerations that support screening for depression in an individual patient … For diagnostic accuracy (KQ2), we examined studies of the Patient Health Questionnaire (PHQ) or Edinburgh … Trials had to use population-based screening to identify eligible patients. … Efficacy and Safety of Screening for Postpartum Depression.
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - Conclusion: Consideration of the safety of primary prevention with aspirin requires an individualized … Second, safety is assessed by eliminating candidates with a history of bleeding with- out reversible … Finally, for pa- tients without safety concerns, aspirin is recommended for those with a clear CVD benefit … In terms of safety, some medications (for example, antiplatelet or anticoagulant drugs) may be considered … A study to assess the efficacy and safety of enteric-coated acetyl- salicylic acid in patients with moderate
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
    July 08, 2002 - Clinicians should inform patients of the potential benefits and harms of chemoprevention. … some high-risk women but will depend on breast cancer risk, risk for potential harms, and individual patient … Clinicians can use this information to help individual patients considering tamoxifen therapy estimate … efficacy for breast cancer chemoprevention are under way, including a trial comparing efficacy and safety
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - Clinicians should inform patients of the potential benefits and harms of chemoprevention. … some high-risk women but will depend on breast cancer risk, risk for potential harms, and individual patient … Clinicians can use this information to help individual patients considering tamoxifen therapy estimate … efficacy for breast cancer chemoprevention are under way, including a trial comparing efficacy and safety
  20. www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
    September 21, 2015 - with established effectiveness and safety (previously stated). … The “5 A's” include: 1) Asking every patient about tobacco use, 2) Advising them to quit, 3) Assessing … In 2012, the FDA issued a safety communication indicating a nonsignificant increase in major adverse … Chantix (varenicline): safety communication—updated safety review on the risk of cardiovascular adverse … American College of Preventive Medicine practice policy: tobacco-cessation patient counseling.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: